Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)
Clinical trial NCT04332744 · COMPLETED
Trial details
- NCT number
- NCT04332744
- Sponsor
- MedSIR
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-02
- Primary completion
- 2025-05-06
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.